Genetic Proliferation Tracing Reveals a Rapid Cell Cycle Withdrawal in Preadolescent Cardiomyocytes.
Wenjuan Pu,Mingjun Zhang,Xiuxiu Liu,Lingjuan He,Jie Li,Ximeng Han,Kathy O Lui,Ben He,Bin Zhou
DOI: https://doi.org/10.1161/circulationaha.121.057019
IF: 37.8
2022-01-01
Circulation
Abstract:HomeCirculationVol. 145, No. 5Genetic Proliferation Tracing Reveals a Rapid Cell Cycle Withdrawal in Preadolescent Cardiomyocytes Free AccessLetterPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyRedditDiggEmail Jump toFree AccessLetterPDF/EPUBGenetic Proliferation Tracing Reveals a Rapid Cell Cycle Withdrawal in Preadolescent Cardiomyocytes Wenjuan Pu, PhD, Mingjun Zhang, BS, Xiuxiu Liu, BS, Lingjuan He, PhD, Jie Li, BS, Ximeng Han, BS, Kathy O. Lui, PhD, Ben He, MD, PhD and Bin Zhou, MD, PhD Wenjuan PuWenjuan Pu State Key Laboratory of Cell Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China (W.P., M.Z., X.L., L.H., J.L., X.H., B.Z.). , Mingjun ZhangMingjun Zhang State Key Laboratory of Cell Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China (W.P., M.Z., X.L., L.H., J.L., X.H., B.Z.). , Xiuxiu LiuXiuxiu Liu https://orcid.org/0000-0002-3807-5417 State Key Laboratory of Cell Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China (W.P., M.Z., X.L., L.H., J.L., X.H., B.Z.). , Lingjuan HeLingjuan He School of Life Sciences, Westlake University, Hangzhou, China (L.H.). , Jie LiJie Li State Key Laboratory of Cell Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China (W.P., M.Z., X.L., L.H., J.L., X.H., B.Z.). , Ximeng HanXimeng Han State Key Laboratory of Cell Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China (W.P., M.Z., X.L., L.H., J.L., X.H., B.Z.). , Kathy O. LuiKathy O. Lui https://orcid.org/0000-0002-1616-3643 Department of Chemical Pathology; and Li Ka Shing Institute of Health Sciences, Prince of Wales Hospital, The Chinese University of Hong Kong, China (K.O.L.). , Ben HeBen He Correspondence to: Ben He, MD, PhD, Shanghai Chest Hospital, No. 241, Huaihai West Road, Shanghai, China, Email E-mail Address: [email protected] or Bin Zhou, MD, PhD, 320 Yueyang Road, A2112, Shanghai, China. Email E-mail Address: [email protected] Department of Cardiology, Shanghai Chest Hospital, Shanghai Jiaotong University, China (B.H.). and Bin ZhouBin Zhou https://orcid.org/0000-0001-5278-5522 School of Life Science and Technology, ShanghaiTech University, China (B.Z.). School of Life Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, China (B.Z.). Originally published31 Jan 2022https://doi.org/10.1161/CIRCULATIONAHA.121.057019Circulation. 2022;145:410–412During embryonic development, the mammalian heart grows mainly by an increase in the number of cardiomyocytes. After birth, there is a rapid reduction in cardiomyocyte proliferation that is further decelerated from the neonatal to adolescent stage. A recent study from Naqvi et al suggests that a second wave of cell-cycle activity occurs during preadolescence, contributing to ≈40% increase in the number of cardiomyocytes present in postnatal days (P) 14 to 18.1 However, subsequent studies through stereological quantification and EdU (5-ethynyl-2´-deoxyuridine)/BrdU (bromodeoxyuridine/5-bromo-2´-deoxyuridine) reveal that the number of cardiomyocytes is mostly settled within the early neonatal stage; a preadolescent burst is not detected.2,3 Naqvi et al argued that these methods are limited by random sampling of only 1% to 2% of cardiomyocytes that do not reflect the heterogeneity of the entire heart.4 They also noted that the antiproliferative effects, as well as potential toxicity of BrdU/EdU, could preclude accurate quantification, and therefore evidence of proliferative burst during preadolescence could not be fully refuted.4 Furthermore, considering that the time-to–peak hormonal influence on cardiomyocyte proliferation could also be affected by the litter size, sex, and other husbandry variations, it remains technically challenging for different laboratories to reproduce a highly synchronized proliferation rate within a short window of time. Nonetheless, these controversies prompt us to reassess it using an independent genetic approach.Recently, we reported a genetic system, ProTracer (Proliferation Tracer), that continuously records cell proliferation in vivo.5 ProTracer does not rely on EdU/BrdU incorporation, preventing potentially inhibitory or toxic chemical effects on cell cycling and survival. It also permits continuous recording of cell-proliferative events in any defined time window. We generated 3 independent ProTracers based on the frequently used cell-cycle markers Ki67 (Mki67/maker of proliferation Ki-67) and Ccna2 (Cyclin A2). In the design of our first genetic system, Ki67-Cre-rox-ER-rox (Ki67-CrexER) did not harbor any Cre (cyclization recombination enzyme) activity before ER (estrogen receptor) was removed by inducible DreER (Figure A). In R26 [Rosa26]-DreER [D6 site-specific DNA recombinase];Ki67-CrexER;R26-GFP mice, a single tamoxifen (Tam) injection induced Dre-rox recombination and subsequently switched Ki67-CrexER into Ki67-Cre, thus priming ProTracer for capturing Ki67-expressing cells with a permanent genetic marker GFP ([green fluorescent protein] Figure A). Tam was injected at P0, P6, P12, and P18, and hearts were collected for analysis at 6 days after each time point (Figure B). Therefore, we quantified the cell-cycle activity within 4 checkpoints (ie, the first checkpoint occurred on P0–P6; the second on P6–P12; the third on P12–P18; and the fourth on P18–P24. Fluorescence-activated cell sorting analysis revealed the percentage of GFP-expressing cardiomyocytes to be 30.88 ± 2.13% at the first checkpoint, dropping to 10.34 ± 1.08%, 2.68 ± 0.39%, and 0.22 ± 0.033% in the second, third, and fourth checkpoints, respectively (Figure C). Similarly, immunostaining for GFP and TNNI3 (troponin I3, cardiac type) on heart sections revealed 3662.77 ± 83.68 GFP-expressing cardiomyocytes per 10× field within the first checkpoint that dramatically dropped to 1434.91 ± 67.92, 205.23 ± 25.96, and 13.12 ± 1.45 in subsequent checkpoints, respectively (Figure D). Considering that the third checkpoint (P12–P18) should mark P14 night through P15, our quantification data did not demonstrate the preadolescent proliferative burst of cardiomyocytes. Instead, the magnitude of cardiomyocyte proliferation at the third checkpoint was close to that of the fourth, suggesting a rapid cell-cycle withdrawal in cardiomyocytes from birth to adolescence.Download figureDownload PowerPointFigure. Genetic proliferation tracing reveals rapid cell-cycle withdrawal in preadolescent CMs. A, Schematic showing the strategy for tracing cell cycles using dual recombinases. B, Schematic showing experimental design. C, FACS analysis and quantification data of the percentage of CMs expressing GFP from P6, P12, P18, and P24 mice with tracing period of first, second, third, and fourth time windows, respectively. Data are mean±SEM; n = 5. D, Immunostaining for GFP and TNNI3 on P6, P12, P18, and P24 heart sections. Arrowheads, GFP+ CMs. D, right, GFP+ CM number per 10× field. Data are mean±SEM; n = 5. E, Fluorescence image of E13.5 heart section showing mTnG expression in TNNI3+ CMs. F, Schematic showing Strategy 2. G, Fluorescence image showing mTnG expression in CMs (arrowheads) of P6, P12, P18, and P24 hearts. G, right, Quantification of mTnG+ CM number per 10× field. Data are mean±SEM; n = 5. H, Schematic showing Strategy 3. I, Immunostaining for GFP and TNNI3 on P6, P12, P18, and P24 heart sections. Arrowheads, GFP+ CMs. I, right, Quantification of GFP+ CM number per 10× field. Data are mean±SEM; n = 5. One-way ANOVA was performed for multiple-group comparisons followed by the Tukey multiple comparisons test. *P<0.05. C, D, G, and I, Trend test is significant (P<0.05). Yellow scale bar = 1 mm; white scale bars = 100 µm. ACTB indicates Actin Beta; CAG, CAG promoter, which is a strong synthetic promoter; Ccna2, Cyclin A2; Cre, Cyclization Recombination Enzyme; DreER, Dre (D6 site-specific DNA recombinase) and ER (estrogen receptor); ERT2, estrogen receptor type 2; FACS, fluorescence-activated cell sorting; FITC, Fluorescein Isothiocyanate; GFP, green fluorescent protein; Ki67, Mki67/maker of proliferation Ki-67; loxP, locus of X (cross)-overinP1; mTnG, membrane tdTomato and nuclear green fluorescent protein; ns, nonsignificant; P, postnatal day; R26, Rosa 26; STOP, trascriptional stop cassette; Tam, tamoxifen; TNNI3, troponin I3, cardiac type; and Tnnt2, troponin T2.To trace cardiomyocyte-specific cell-cycle activity, we adopted an iteration of the generic ProTracer by generating a cardiomyocyte-specific reporter Tnnt2 (troponin T2)-mTnG. Germline removal of the loxP-flanked STOP (transcriptional stop) cassette by ACTB (Actin Beta)-Cre yielded specific expression of mT and nG in TNNI3+ cardiomyocytes (Figure E). In R26-DreER;Ki67-CrexER;Tnnt2-mTnG mice, Tam treatment primed the ProTracer to record cardiomyocyte-specific cell-cycle activity in membrane tdTomato and nuclear GFP (mTnG)–expressing cells (Figure F, Strategy 2). We adopted a similar regime of Tam treatment and examined heart tissues collected from the same checkpoints as Strategy 1 (Figure B). Fluorescence images of heart sections collected at P6, P12, P18, and P24 revealed a pronounced drop of mTnG-expressing cardiomyocytes from the first to fourth checkpoints, with the number at the third checkpoint window being very low and close to that of the fourth checkpoint (Figure G). Our data demonstrated a rapid decline in cardiomyocyte-specific cell-cycle activity from birth to adolescence.We independently generated a Ccna2-based ProTracer to record cell-cycle events at any defined time window (Figure H, Strategy 3). Immunostaining for TNNI3 and GFP on heart sections revealed that a substantial portion of cardiomyocytes expressed GFP at the first checkpoint (Figure I). The dramatic reduction of GFP-expressing cardiomyocytes was also noticed at subsequent checkpoints (Figure I). Taken together, this proliferation tracing data showed a rapid and continuous drop in cycling cardiomyocytes from birth to adolescence, presenting an argument against evidence of a proliferative burst of cardiomyocytes during preadolescence.1,4Article InformationData sharing: The data that support the findings of this study and research materials, as well as experimental procedures and protocols, are available from the corresponding author upon reasonable request. The mouse study is done in accordance with the institutional guidelines.AcknowledgmentsThe authors thank Shanghai Biomodel Organism Co., Ltd. for generation of ProTracer and Tnnt2-mTnG (Tnnt2 [Troponin T2]-mTnG [membrane tdTomato and nuclear green fluorescent protein]). mice.Sources of FundingThis work was supported by the National Science Foundation of China (82088101, 81830010, 31730112, 32050087, 91849202, 31625019, 32100592) and the National Key Research and Development Program of China (2019YFA0110403, 2019YFA0802000, 2021YFA0805100, 2018YFA0108100).Nonstandard Abbreviations and AcronymsBrdUbromodeoxyuridine/5-bromo-2´-deoxyuridineCMcardiomyocyteEdU5-ethynyl-2´-deoxyuridineFACSfluorescence-activated cell sortingmTnGmembrane tdTomato and nuclear green fluorescent proteinTNNI3troponin I, cardiac muscleDisclosures None.Footnotes*W. Pu and M. Zhang contributed equally.For Sources of Funding and Disclosures, see page 411.Correspondence to: Ben He, MD, PhD, Shanghai Chest Hospital, No. 241, Huaihai West Road, Shanghai, China, Email [email protected]com or Bin Zhou, MD, PhD, 320 Yueyang Road, A2112, Shanghai, China. Email [email protected]ac.cnReferences1. Naqvi N, Li M, Calvert JW, Tejada T, Lambert JP, Wu J, Kesteven SH, Holman SR, Matsuda T, Lovelock JD, et al.. A proliferative burst during preadolescence establishes the final cardiomyocyte number.Cell. 2014; 157:795–807. doi: 10.1016/j.cell.2014.03.035CrossrefMedlineGoogle Scholar2. Alkass K, Panula J, Westman M, Wu TD, Guerquin-Kern JL, Bergmann O. No evidence for cardiomyocyte number expansion in preadolescent mice.Cell. 2015; 163:1026–1036. doi: 10.1016/j.cell.2015.10.035CrossrefMedlineGoogle Scholar3. Soonpaa MH, Zebrowski DC, Platt C, Rosenzweig A, Engel FB, Field LJ. Cardiomyocyte cell-cycle activity during preadolescence.Cell. 2015; 163:781–782. doi: 10.1016/j.cell.2015.10.037CrossrefMedlineGoogle Scholar4. Naqvi N, Singh R, Iismaa SE, Li M, Calvert JW, Martin DI, Harvey RP, Graham RM, Husain A. Cardiomyocytes replicate and their numbers increase in young hearts.Cell. 2015; 163:783–784. doi: 10.1016/j.cell.2015.10.038CrossrefMedlineGoogle Scholar5. He L, Pu W, Liu X, Zhang Z, Han M, Li Y, Huang X, Han X, Li Y, Liu K, et al.. Proliferation tracing reveals regional hepatocyte generation in liver homeostasis and repair.Science. 2021; 371:eabc4346. doi: 10.1126/science.abc4346CrossrefMedlineGoogle Scholar Previous Back to top Next FiguresReferencesRelatedDetailsCited By Young A, Bradley L and Wolf M (2022) In Vivo Methods to Monitor Cardiomyocyte Proliferation, Journal of Cardiovascular Development and Disease, 10.3390/jcdd9030073, 9:3, (73) February 1, 2022Vol 145, Issue 5Article InformationMetrics © 2022 American Heart Association, Inc.https://doi.org/10.1161/CIRCULATIONAHA.121.057019PMID: 35100020 Originally publishedJanuary 31, 2022 Keywordspreadolescentproliferationcardiomyocytescell cyclegenetic tracingPDF download Advertisement SubjectsBasic Science Research